Since its first venture round in 1992, Cell Therapeutics Inc. (NASDAQ:CTIC; Milan:CTIC) has raised $1.4 billion, including $743.3 million in equity and $662.1 million in debt. Since 2006, the company has exchanged, extinguished or repurchased $232.1 million of its debt. Selected events along with the company's financings are listed below. $M; Source: BCIQ: BioCentury Online Intelligence; Cell Therapeutics; SEC documents

1993    October - Files IND for lisofylline (CT-1501R)